Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes

The lung-resident immune mechanisms driving resolution of SARS-CoV-2 infection in humans remain elusive. Using mice co-engrafted with a genetically matched human immune system and fetal lung xenograft (fLX), we mapped the immunological events defining resolution of SARS-CoV-2 infection in human lung tissues. Viral infection is rapidly cleared from fLX following a peak of viral replication. Acute replication results in the emergence of cell subsets enriched in viral RNA, including extravascular inflammatory monocytes (iMO) and macrophage-like T-cells, which dissipate upon infection resolution. iMO display robust antiviral responses, are transcriptomically unique among myeloid lineages, and their emergence associates with the recruitment of circulating CD4+ monocytes. Consistently, mice depleted for human CD4+ cells but not CD3+ T-cells failed to robustly clear infectious viruses and displayed signatures of chronic infection. Our findings uncover the transient differentiation of extravascular iMO from CD4+ monocytes as a major hallmark of SARS-CoV-2 infection resolution and open avenues for unravelling viral and host adaptations defining persistently active SARS-CoV-2 infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

bioRxiv : the preprint server for biology - (2024) vom: 08. März

Sprache:

Englisch

Beteiligte Personen:

Kenney, Devin [VerfasserIn]
O'Connell, Aoife K [VerfasserIn]
Tseng, Anna E [VerfasserIn]
Turcinovic, Jacquelyn [VerfasserIn]
Sheehan, Meagan L [VerfasserIn]
Nitido, Adam D [VerfasserIn]
Montanaro, Paige [VerfasserIn]
Gertje, Hans P [VerfasserIn]
Ericsson, Maria [VerfasserIn]
Connor, John H [VerfasserIn]
Vrbanac, Vladimir [VerfasserIn]
Crossland, Nicholas A [VerfasserIn]
Harly, Christelle [VerfasserIn]
Balazs, Alejandro B [VerfasserIn]
Douam, Florian [VerfasserIn]

Links:

Volltext

Themen:

Preprint

Anmerkungen:

Date Revised 21.03.2024

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1101/2024.03.08.583965

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36986154X